(Q34999406)

5 August 2017

1 reference

title

Treatment of testicular germ-cell cancer: a cochrane evidence-based systematic review (English)

1 reference

5 August 2017

1 reference

Shelley MD

1

1 reference

5 August 2017

Burgon K

series ordinal

2

1 reference

5 August 2017

Mason MD

series ordinal

3

1 reference

5 August 2017

publication date

1 October 2002

1 reference

5 August 2017

published in

Cancer Treatment Reviews

1 reference

5 August 2017

volume

28

1 reference

5 August 2017

issue

5

1 reference

5 August 2017

page(s)

237-253

1 reference

Testicular cancer in nine northern european countries

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Prophylactic use of tropisetron or metoclopramide during adjuvant abdominal radiotherapy of seminoma stage I: a randomised, open trial in 23 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

The effect of antiemetics and reduced radiation fields on acute gastrointestinal morbidity of adjuvant radiotherapy in stage I seminoma of the testis: a randomized pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Surveillance following orchidectomy for stage I seminoma of the testis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Results of a policy of surveillance in stage I testicular seminoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Surveillance after orchiectomy for stage I seminoma of the testis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Orchidectomy alone for stage I seminoma of the testis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Surveillance following orchidectomy for stage I testicular seminoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Treatment of testicular cancer and the development of secondary malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: should it be tested in a randomized trial against radiotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Adjuvant treatment of clinical stage I seminoma: is a single course of carboplatin sufficient?

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Surveillance alone versus radiotherapy after orchiectomy for clinical stage I nonseminomatous testicular cancer. Danish Testicular Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Management preferences in stage I non-seminomatous germ cell tumours of the testis: an investigation among patients, controls and oncologists

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: Long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Resear

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. Australasian Germ Cell Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization for Research and Treatment of Ca

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

The role of maintenance therapy in disseminated testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

High-dose versus low-dose vinblastine in cisplatin-vinblastine-bleomycin combination chemotherapy of non-seminomatous testicular cancer: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. Australian and New Zealand Germ Cell Trial Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

A 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Early intensified chemotherapy with autologous bone marrow transplantation in first line treatment of poor risk non-seminomatous germ cell tumours. Preliminary results of a French randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer a southwest oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of C

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. European Organization for Research and Treatment of Cancer, Genito-Urinary Group, and the Medical Research Council Testicular Cancer Working

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

A randomized trial of cytoreductive surgery followed by chemotherapy versus chemotherapy alone in bulky stage testicular cancer with poor prognostic features

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Sexual dysfunction after treatment for testicular cancer: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Sexual functioning after treatment for testicular cancer--review and meta-analysis of 36 empirical studies between 1975-2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

Evaluation of adjuvant psychological therapy in patients with testicular cancer: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900059-2

7 January 2021

10.1016/S0305-7372(02)00059-2

Identifiers

DOI

1 reference

5 August 2017

1 reference